{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:07:35Z","timestamp":1791929255433,"version":"4.3.4"},"reference-count":74,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014641","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T18:37:08Z","timestamp":1629484628000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV"],"prefix":"10.1002","volume":"2021","author":[{"given":"Ruvandhi R","family":"Nathavitharana","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases; Beth Israel Deaconess Medical Center, Harvard Medical School; Boston USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Lederer","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases; Boston Medical Center; Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marty","family":"Chaplin","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Bjerrum","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Research Unit of Infectious Diseases; University of Southern Denmark; Odense Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R","family":"Steingart","sequence":"additional","affiliation":[{"name":"Honorary Research Fellow; Department of Clinical Sciences, Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maunank","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases; John Hopkins University School of Medicine; Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD014641-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S2352-3018(19)30266-8","article-title":"Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial","volume":"7","author":"Grant","year":"2020","journal-title":"Lancet HIV"},{"issue":"10144","key":"10.1002\/14651858.CD014641-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(18)31267-4","article-title":"Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial","volume":"392","author":"Gupta-Wright","year":"2018","journal-title":"Lancet"},{"issue":"10024","key":"10.1002\/14651858.CD014641-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(15)01092-2","article-title":"Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial","volume":"387","author":"Peter","year":"2016","journal-title":"Lancet"},{"issue":"25","key":"10.1002\/14651858.CD014641-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa1910708","article-title":"Systematic or test-guided treatment for tuberculosis in HIV-Infected adults","volume":"382","author":"Blanc","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD014641-BIB0005|cit5","first-page":"2","article-title":"Operational feasibility and diagnostic yield of urine TB-LAM testing among HIV-infected patients hospitalized with sepsis and septic shock in Uganda","volume":"199","author":"Cummings","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD014641-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"e1002776","DOI":"10.1371\/journal.pmed.1002776","article-title":"Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: derivation and external validation cohort study","volume":"16","author":"Gupta-Wright","year":"2019","journal-title":"PLOS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD014641-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/QAI.0000000000002206","article-title":"Should urine-LAM tests be used in TB symptomatic HIV-positive patients when no CD4 count is available? A prospective observational cohort study from Malawi","volume":"83","author":"Huerga","year":"2020","journal-title":"Journal of Acquired Immune Deficifiency Syndromes"},{"issue":"11","key":"10.1002\/14651858.CD014641-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.5588\/ijtld.18.0099","article-title":"Urinary LAM grade, culture positivity, and mortality among HIV-infected South African out-patients","volume":"22","author":"Kubiak","year":"2018","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"1","key":"10.1002\/14651858.CD014641-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1672366","DOI":"10.1080\/16549716.2019.1672366","article-title":"Feasibility of using Determine TB-LAM to diagnose tuberculosis in HIV-positive patients in programmatic conditions: a multisite study","volume":"12","author":"Mathabire Rucker","year":"2019","journal-title":"Global Health Action"},{"issue":"8","key":"10.1002\/14651858.CD014641-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.21037\/jtd.2019.07.69","article-title":"Urine lipoarabinomannan (LAM) and antimicrobial usage in seriously-ill HIV-infected patients with sputum smear-negative pulmonary tuberculosis","volume":"11","author":"Mthiyane","year":"2019","journal-title":"Journal of Thoracic Disease"},{"key":"10.1002\/14651858.CD014641-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijid.2018.09.024","article-title":"Does the use of adjunct urine lipopolysaccharide lipoarabinomannan in HIV-infected hospitalized patients reduce the utilization of healthcare resources? A post hoc analysis of the LAM multi-country randomized controlled trial","volume":"79","author":"Naidoo","year":"2019","journal-title":"International Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD014641-BIB0012|cit12","unstructured":"Alere DetermineTM TB LAM Ag product information www.globalpointofcare.abbott\/en\/product-details\/determine-tb-lam.html"},{"issue":"8","key":"10.1002\/14651858.CD014641-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/trstmh\/trw056","article-title":"Xpert MTB\/RIF - why the lack of morbidity and mortality impact in intervention trials?","volume":"110","author":"Auld","year":"2016","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD014641-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64(4)","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD014641-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5588\/ijtld.14.0680","article-title":"F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy","volume":"19","author":"Barrera","year":"2015","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"10","key":"10.1002\/14651858.CD014641-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011420.pub3","article-title":"Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV","author":"Bjerrum","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD014641-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"ofz530","DOI":"10.1093\/ofid\/ofz530","article-title":"Diagnostic accuracy of a novel and rapid lipoarabinomannan test for diagnosing tuberculosis among people with human immunodeficiency virus","volume":"7","author":"Bjerrum","year":"2020","journal-title":"Open Forum Infectious Diseases"},{"issue":"1-3","key":"10.1002\/14651858.CD014641-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1472-9792(02)00089-6","article-title":"Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis","volume":"83","author":"Brennan","year":"2003","journal-title":"Tuberculosis"},{"issue":"2","key":"10.1002\/14651858.CD014641-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2958.2004.04183.x","article-title":"Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response","volume":"53","author":"Briken","year":"2004","journal-title":"Molecular Microbiology"},{"issue":"5","key":"10.1002\/14651858.CD014641-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"e1003113","DOI":"10.1371\/journal.pmed.1003113","article-title":"Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: a meta-analysis of individual in- and outpatient data","volume":"17","author":"Broger","year":"2020","journal-title":"PLOS Medicine"},{"issue":"8","key":"10.1002\/14651858.CD014641-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S2213-2600(15)00198-8","article-title":"Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB\/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial","volume":"3","author":"Calligaro","year":"2015","journal-title":"Lancet Respiratory Medicine"},{"issue":"8","key":"10.1002\/14651858.CD014641-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S2214-109X(15)00100-X","article-title":"Xpert MTB\/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB\/RIF","volume":"3","author":"Churchyard","year":"2015","journal-title":"Lancet Global Health"},{"key":"10.1002\/14651858.CD014641-BIB0023|cit23","unstructured":"Veritas Health Innovation Covidence"},{"issue":"11","key":"10.1002\/14651858.CD014641-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"e1001760","DOI":"10.1371\/journal.pmed.1001760","article-title":"Impact of Xpert MTB\/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial","volume":"11","author":"Cox","year":"2014","journal-title":"PLOS Medicine"},{"key":"10.1002\/14651858.CD014641-BIB0025|cit25","unstructured":"Deeks JJ Higgins JPT Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\u00a0"},{"key":"10.1002\/14651858.CD014641-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1136\/bmj.e686","article-title":"Assessing the value of diagnostic tests: a framework for designing and evaluating trials","volume":"344","author":"di Ruffano","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD014641-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(18)30458-3","article-title":"Effect of Xpert MTB\/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis","volume":"7","author":"Di Tanna","year":"2019","journal-title":"Lancet Global Health"},{"issue":"4","key":"10.1002\/14651858.CD014641-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"e006833","DOI":"10.1136\/bmjopen-2014-006833","article-title":"Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study","volume":"5","author":"Drain","year":"2015","journal-title":"BMJ Open"},{"issue":"3","key":"10.1002\/14651858.CD014641-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"ofx167","DOI":"10.1093\/ofid\/ofx167","article-title":"Clinic-based urinary lipoarabinomannan as a biomarker of clinical disease severity and mortality among antiretroviral therapy-naive human immunodeficiency virus-infected adults in South Africa","volume":"4","author":"Drain","year":"2017","journal-title":"Open Forum Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD014641-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"20714","DOI":"10.7448\/IAS.19.1.20714","article-title":"TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis","volume":"19","author":"Ford","year":"2016","journal-title":"Journal of the International AIDS Society"},{"key":"10.1002\/14651858.CD014641-BIB0031|cit31","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"issue":"15","key":"10.1002\/14651858.CD014641-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/QAD.0000000000000802","article-title":"Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis","volume":"29","author":"Gupta","year":"2015","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD014641-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12916-016-0603-9","article-title":"Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis","volume":"14","author":"Gupta-Wright","year":"2016","journal-title":"BMC Medicine"},{"issue":"S7","key":"10.1002\/14651858.CD014641-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"S686","DOI":"10.1093\/infdis\/jix388","article-title":"Finding the missing patients with tuberculosis: lessons learned from patient-pathway analyses in 5 countries","volume":"216","author":"Hanson","year":"2017","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD014641-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012972.pub2","article-title":"Impact of the diagnostic test Xpert MTB\/RIF on patient outcomes for tuberculosis","author":"Haraka","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014641-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014641-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","article-title":"The GRADE Working Group clarifies the construct of certainty of evidence","volume":"87","author":"Hultcrantz","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD014641-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12879-018-3256-9","article-title":"HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town","volume":"18","author":"Kaplan","year":"2018","journal-title":"BMC Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD014641-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"e0174097","DOI":"10.1371\/journal.pone.0174097","article-title":"Measuring mortality due to HIV-associated tuberculosis among adults in South Africa: comparing verbal autopsy, minimally-invasive autopsy, and research data","volume":"12","author":"Karat","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1002\/14651858.CD014641-BIB0040|cit40","unstructured":"Xpert MTB\/RIF and Xpert MTB\/RIF Ultra assays for active tuberculosis and rifampicin resistance in children Cochrane Database of Systematic Reviews 2020 8 10.1002\/14651858.CD013359.pub2"},{"key":"10.1002\/14651858.CD014641-BIB0041|cit41","doi-asserted-by":"crossref","unstructured":"Xpert MTB\/RIF Ultra and Xpert MTB\/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults Cochrane Database of Systematic Reviews 2021 1 10.1002\/14651858.CD012768.pub3","DOI":"10.1002\/14651858.CD012768.pub3"},{"issue":"11","key":"10.1002\/14651858.CD014641-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/cid\/ciy011","article-title":"Urine tuberculosis lipoarabinomannan predicts mortality in hospitalized human immunodeficiency virus-infected children","volume":"66","author":"LaCourse","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD014641-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2334-12-103","article-title":"Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review","volume":"12","author":"Lawn","year":"2012","journal-title":"BMC Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD014641-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/trstmh\/trw008","article-title":"Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications","volume":"110","author":"Lawn","year":"2016","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD014641-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"e1-33","DOI":"10.1093\/cid\/ciw694","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD014641-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41564-019-0380-2","article-title":"A systematic review of biomarkers to detect active tuberculosis","volume":"4","author":"MacLean","year":"2019","journal-title":"Nature Microbiology"},{"issue":"6","key":"10.1002\/14651858.CD014641-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1183\/09031936.00025711","article-title":"Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis","volume":"38","author":"Minion","year":"2011","journal-title":"European Respiratory Journal"},{"issue":"7","key":"10.1002\/14651858.CD014641-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD014641-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"ofu038","DOI":"10.1093\/ofid\/ofu038","article-title":"Impact of Xpert MTB\/RIF on antiretroviral therapy-associated tuberculosis and mortality: a pragmatic randomized controlled trial","volume":"1","author":"Mupfumi","year":"2014","journal-title":"Open Forum Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD014641-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"1176-83","DOI":"10.1093\/cid\/ciy590","article-title":"Screening for tuberculosis with Xpert MTB\/RIF versus fluorescent microscopy among adults newly diagnosed with HIV in rural Malawi: a cluster randomized trial (CHEPETSA)","volume":"68","author":"Ngwira","year":"2019","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD014641-BIB0051|cit51","first-page":"e25162","article-title":"High HIV and active tuberculosis prevalence and increased mortality risk in adults with symptoms of TB: a systematic review and meta-analyses","volume":"21","author":"Nliwasa","year":"2018","journal-title":"Journal of the International\u00a0AIDS Society"},{"key":"10.1002\/14651858.CD014641-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1002\/14651858.CD014641-BIB0053|cit53","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2020"},{"key":"10.1002\/14651858.CD014641-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE Working Group. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014641-BIB0055|cit55","doi-asserted-by":"crossref","unstructured":"Saran K Masini T Chikwanha I Paton G Scourse R Kahn P Countries are out of step with international recommendations for tuberculosis testing, treatment, and care: findings from a 29-country survey of policy adoption and implementation www.biorxiv.org\/content\/biorxiv\/early\/2019\/02\/01\/533851.full.pdf","DOI":"10.1101\/533851"},{"issue":"3","key":"10.1002\/14651858.CD014641-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"e015107","DOI":"10.1371\/journal.pone.0151073","article-title":"Impact of molecular diagnostics for tuberculosis on patient-important outcomes: a systematic review of study methodologies","volume":"11","author":"Schumacher","year":"2016","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1002\/14651858.CD014641-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S2214-109X(18)30493-5","article-title":"The impact of Xpert MTB\/RIF - do we have a final answer?","volume":"7","author":"Schumacher","year":"2019","journal-title":"Lancet Global Health"},{"key":"10.1002\/14651858.CD014641-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jclinepi.2016.01.032","article-title":"GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health","volume":"76","author":"Sch\u00fcnemann","year":"2016","journal-title":"Journal of Clinical Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD014641-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/JCM.00363-10","article-title":"Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis","volume":"48","author":"Shah","year":"2010","journal-title":"Journal of Clinical Microbiology"},{"issue":"5","key":"10.1002\/14651858.CD014641-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011420.pub2","article-title":"Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults","author":"Shah","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014641-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Xpert MTB\/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms Cochrane Database of Systematic Reviews 2021 3 10.1002\/14651858.CD013694.pub2","DOI":"10.1002\/14651858.CD013694.pub2"},{"issue":"1","key":"10.1002\/14651858.CD014641-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s15010-016-0960-5","article-title":"Association of HIV infection with extrapulmonary tuberculosis: a systematic review","volume":"45","author":"Shivakoti","year":"2017","journal-title":"Infection"},{"issue":"8","key":"10.1002\/14651858.CD014641-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/cid\/ciaa024","article-title":"\u201cSILVAMP TB LAM\u201d rapid urine tuberculosis test predicts mortality in patients hospitalized with human immunodeficiency virus in South Africa","volume":"71","author":"Sossen","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD014641-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5588\/ijtld.13.0585","article-title":"Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review","volume":"18","author":"Sreeramareddy","year":"2014","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"343","key":"10.1002\/14651858.CD014641-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"22","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"9915","key":"10.1002\/14651858.CD014641-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0140-6736(13)62073-5","article-title":"Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB\/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial","volume":"383","author":"Theron","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD014641-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1473-3099(13)70360-8","article-title":"Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?","volume":"14","author":"Theron","year":"2014","journal-title":"Lancet Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD014641-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"e0123252","DOI":"10.1371\/journal.pone.0123252","article-title":"Impact on patients' treatment outcomes of Xpert MTB\/RIF implementation for the diagnosis of tuberculosis: follow-up of a stepped-wedge randomized clinical trial","volume":"10","author":"Trajman","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1002\/14651858.CD014641-BIB0069|cit69","unstructured":"World Health Organization Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with tuberculosis. Second Edition - June 2018 http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/272644\/9789241514101-eng.pdf"},{"key":"10.1002\/14651858.CD014641-BIB0070|cit70","unstructured":"World Health Organization WHO consolidated guidelines on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detection. Licence: CC BY-NC-SA 3.0 IGO who.int\/publications\/i\/item\/who-consolidated-guidelines-on-tuberculosis-module-3-diagnosis---rapid-diagnostics-for-tuberculosis-detection"},{"key":"10.1002\/14651858.CD014641-BIB0071|cit71","unstructured":"World Health Organization Global Tuberculosis Report 2020 apps.who.int\/iris\/bitstream\/handle\/10665\/336069\/9789240013131-eng.pdf"},{"key":"10.1002\/14651858.CD014641-BIB0072|cit72","unstructured":"World Health Organization WHO Operational Handbook on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detection. Licence: CC BY-NC-SA 3.0 IGO www.who.int\/publications\/i\/item\/who-operational-handbook-on-tuberculosis-module-3-diagnosis---rapid-diagnostics-for-tuberculosis-detection"},{"key":"10.1002\/14651858.CD014641-BIB0073|cit73","unstructured":"World Health Organization High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting. WHO\/HTM\/TB\/2014.18 who.int\/iris\/handle\/10665\/135617"},{"key":"10.1002\/14651858.CD014641-BIB0074|cit74","unstructured":"Steingart KR Nathavitharan RR Lederer P Chaplin M Bjerrum S Shah M Impact of diagnostic strategies using lateral flow urine lipoarabinomannan assay on health outcomes for tuberculosis in people living with HIV. PROSPERO 2019 CRD42019153471 www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=153471"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T08:03:48Z","timestamp":1667635428000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014641"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":74,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014641","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]}}}